Royal Bank of Canada’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Royal Bank of Canada’s Portfolio ALXA Stock Details ALXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-3,000	Closed	-$4K	–	7088
2015 Q3	$4K	Hold	3,000	–	–	﹤0.01%	6274
2015 Q2	$3K	Hold	3,000	–	–	﹤0.01%	6346
2015 Q1	$6K	Sell	3,000 -195,213	-98%	-$401K	﹤0.01%	5716
2014 Q4	$295K	Sell	198,213 -1,488	-0.7%	-$2.66K	﹤0.01%	4049
2014 Q3	$465K	Sell	199,701 -1,934	-1%	-$7.38K	﹤0.01%	3533
2014 Q2	$922K	Buy	201,635 +48,959	+32%	+$211K	﹤0.01%	2906
2014 Q1	$676K	Buy	152,676 +2,000	+1%	+$10.3K	﹤0.01%	3111
2013 Q4	$713K	Sell	150,676 -8,820	-6%	-$43.3K	﹤0.01%	3133
2013 Q3	$816K	Buy	159,496 +139,676	+705%	+$657K	﹤0.01%	2953
2013 Q2	$86K	Buy	+19,820	New	+$89.8K	﹤0.01%	4393

Other funds holding ALXA

LPA

Lansdowne Partners Austria Vienna, Austria $29M AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CLOS

Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return

Royal Bank of Canada's ALXA Position: Q4 2015 in Review

Royal Bank of Canada sold out of Alexza Pharmaceuticals Inc (ALXA) in Q4 2015, closing a stake of 3,000 shares — an estimated $4K sold.

Royal Bank of Canada first reported a position in ALXA in Q2 2013 and held it in 10 quarters. The position peaked at $922K in Q2 2014. 26 funds tracked by Wall St. Rank hold ALXA as of Q4 2015.

Royal Bank of Canada reported no remaining Alexza Pharmaceuticals Inc position as of Q4 2015 after selling out during the quarter.
Royal Bank of Canada sold 3,000 Alexza Pharmaceuticals Inc shares in Q4 2015, an estimated $4K.
Royal Bank of Canada first reported a position in Alexza Pharmaceuticals Inc in Q2 2013 and held it in 10 quarters.
Royal Bank of Canada's Alexza Pharmaceuticals Inc position peaked at $922K in Q2 2014.
26 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q4 2015.

Based on Royal Bank of Canada's 13F filing for Q4 2015, filed 16 Feb 2016.